Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON40254
NL-OMON40254
Completed
Not Applicable

Pre-operative treatment with Erythropoietin and iron supplement for prevention of perioperative blood transfusion in cardiac surgery - EPICS study

Catharina-ziekenhuis0 sites100 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Catharina-ziekenhuis
Enrollment
100
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\. Age of 18 years or more undergoing isolated CABG or AVR
  • •2\. Preoperative Hb \< 7 mmol/l.

Exclusion Criteria

  • •1\. Off pump surgery.
  • •2\. Combination surgery.
  • •3\. Re\-operation.
  • •4\. Emergency operation.
  • •5\. Patients with bleeding disturbances;e.g, hemophilia and patients with chronic liver disease.
  • •6\. Concomitant use of cyclosporine prior to, during or following surgery
  • •7\. Female patients who are pregnant or planning to become pregnant.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Pre-operative treatment with Erythropoietin and iron supplement for prevention of perioperative blood transfusion in cardiac surgeryPatients (male and female) scheduled for coronary artery bypass grafting surgery (CABG) or single Aortic Valve replacement (AVR) on conventional cardiopulmonary bypass.Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2012-002076-14-NL100
Terminated
Phase 4
Pre-operative Treatment With Erythropoietin and Iron Supplement in Cardiac SurgeryHeart; Dysfunction Postoperative, Cardiac SurgeryAnemia, Iron-Deficiency
NCT02210949Catharina Ziekenhuis Eindhoven7
Recruiting
Phase 2
Effect of erytropoetin and Ferinject on transfusio
IRCT20221021056256N1The Shahid Beheshty University100
Not yet recruiting
Not Applicable
prophylactic erythropoietiHaematological Disordersanemia in critically ill patients
PACTR201803003169385Asmaa Fawzy Amer100
Recruiting
Phase 3
Evaluating the efficacy of Erythropoietin and Intravenous Iron on transfusion requirements in patients undergoing cardiac surgeryiron deficiency anemia.
IRCT20190121042447N1Tehran University of Medical Sciences154